Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
2,080.00    -62.00 (-2.89%)
Bid:
2,066.00
Ask:
2,070.00
Spread: 4.00 (0.194%)
Market Cap: £3.48b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Organisation Changes

20 Apr 2017 16:00

RNS Number : 9050C
Johnson Matthey PLC
20 April 2017
 

For release at 4.00 pm Thursday 20th April 2017

 

JM at 200 - Aligned for Growth

 

Johnson Matthey announces changes to its organisation

 

In 2017 Johnson Matthey celebrates its 200th year and in May we will launch a refreshed brand identity, "Inspiring science, enhancing life", to reflect our position as first and foremost a science led company which has a major positive impact on people's lives; making the world around us cleaner and healthier.

 

Johnson Matthey has made, and continues to make, significant progress in these areas but in order to perform in the current environment, we must increase our focus and build a more collaborative organisation. This will drive further synergies for customers and create value for shareholders. To achieve this, and to reinforce Johnson Matthey's brand identity, we will move to a group structure of four sectors aligned on the global priorities of cleaner air, the efficient use of natural resources and improved health:

· Clean Air

· Efficient Natural Resources

· Health

· New Markets

 

Clean Air is the new name for Emission Control Technologies Division. John Walker, Executive Director, will continue to lead this sector.

 

Efficient Natural Resources brings together Process Technologies Division and much of Precious Metal Products Division. There is an opportunity to deepen our presence in the chemicals, oil and gas, and industrial markets by enabling our customers to increase their efficient use of resources; making more out of less. Jane Toogood, currently Division Director of Precious Metal Products, will lead this sector.

 

Health will comprise much of our Fine Chemicals Division. Johnson Matthey is well positioned to build in this space through focusing on niche areas where we can differentiate using our expertise in complex chemistry. We will bring in a new leader from outside Johnson Matthey to head this sector. In the interim, Robert MacLeod, Chief Executive, will oversee this sector.

 

New Markets is the new name for our New Businesses Division. In addition to the current portfolio of businesses, it will incorporate the Medical Components business previously included in Precious Metal Products' Noble Metals business, and Fine Chemicals' Catalysis and Chiral Technologies business. Alan Nelson, currently Chief Technology Officer and Division Director of New Businesses, will lead this sector.

 

These changes are with immediate effect.

 

 

Enquiries:

Investor Relations

Simon McGough

Sarah Armstrong

 

Head of Investor Relations

Head of Investor Relations

 

020 7269 8235

020 7269 8426

Katharine Burrow

 

Media

Sally Jones

David Allchurch

Investor Relations Analyst

 

 

Director of Corporate Relations

Tulchan Communications

020 7269 8444

 

 

020 7269 8407

020 7353 4200

www.matthey.com

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEALLEALSXEFF
Date   Source Headline
19th Sep 20194:21 pmRNSDirector/PDMR Shareholding
19th Sep 20197:00 amRNSJohnson Matthey Capital Markets Day
22nd Aug 20193:02 pmRNSDirector/PDMR Shareholding
22nd Aug 20192:55 pmRNSDirector/PDMR Shareholding
22nd Aug 20192:44 pmRNSDirector/PDMR Shareholding
22nd Aug 201911:53 amRNSDirector/PDMR Shareholding
12th Aug 20199:49 amRNSDirector/PDMR Shareholding
9th Aug 20199:45 amRNSDirector/PDMR Shareholding
9th Aug 20199:19 amRNSDirector/PDMR Shareholding
9th Aug 20199:06 amRNSDirector/PDMR Shareholding
8th Aug 20199:53 amRNSDirector/PDMR Shareholding
7th Aug 201912:42 pmRNSDirector/PDMR Shareholding
7th Aug 201912:33 pmRNSDirector/PDMR Shareholding
6th Aug 201911:06 amRNSDirector/PDMR Shareholding
6th Aug 201910:59 amRNSDirector/PDMR Shareholding
6th Aug 201910:54 amRNSDirector/PDMR Shareholding
2nd Aug 201911:40 amRNSDirector/PDMR Shareholding
2nd Aug 201911:33 amRNSDirector/PDMR Shareholding
19th Jul 20199:12 amRNSDirector/PDMR Shareholding
17th Jul 20193:24 pmRNSResult of AGM
17th Jul 20197:00 amRNSJohn Walker to retire; succeeded by Joan Braca
17th Jul 20197:00 amRNSAGM trading update
20th Jun 20192:05 pmRNSDirector/PDMR Shareholding
14th Jun 20197:00 amRNSAnnual Financial Report
30th May 20197:00 amRNSPreliminary results for year ended 31st March 2019
28th May 20197:00 amRNSDirectorate Changes
17th May 20192:03 pmRNSDirector/PDMR Shareholding
18th Apr 20193:41 pmRNSDirector/PDMR Shareholding
1st Apr 20197:00 amRNSDirectorate Change
28th Mar 20197:00 amRNSStrategic developments in eLNO commercialisation
21st Mar 20193:45 pmRNSDirector/PDMR Shareholding
21st Feb 20193:52 pmRNSDirector/PDMR Shareholding
7th Feb 20192:43 pmRNSDirector/PDMR Shareholding
7th Feb 20199:27 amRNSDirector/PDMR Shareholding
7th Feb 20199:25 amRNSDirector/PDMR Shareholding
7th Feb 20199:23 amRNSDirector/PDMR Shareholding
21st Jan 201910:43 amRNSDirector/PDMR Shareholding
17th Jan 20193:39 pmRNSDirector/PDMR Shareholding
21st Dec 20184:21 pmRNSDirector/PDMR Shareholding
11th Dec 201810:17 amRNSDirector/PDMR Shareholding
6th Dec 20185:22 pmRNSHolding(s) in Company
22nd Nov 201812:24 pmRNSDirector/PDMR Shareholding
21st Nov 20187:00 amRNSHalf-year Report
18th Oct 20184:20 pmRNSDirector/PDMR Shareholding
20th Sep 20184:42 pmRNSDirector/PDMR Shareholding
19th Sep 20183:57 pmRNSDirector/PDMR Shareholding
22nd Aug 201811:30 amRNSAlan Ferguson - New Directorship
16th Aug 20182:44 pmRNSDirector/PDMR Shareholding
16th Aug 20181:23 pmRNSDirector/PDMR Shareholding
15th Aug 201811:25 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.